about
Long-term stability of the posterior cornea after laser in situ keratomileusis.Comparison of corneal thickness measurements by ultrasound and scheimpflug photography in eyes that have undergone laser in situ keratomileusis.Corneal allograft reaction associated with nonocular inflammation.UV cross-linking of donor corneas confers resistance to keratolysisOcular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trials.An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eyeHigh-irradiance CXL combined with myopic LASIK: flap and residual stroma biomechanical properties studied ex-vivo.Pivotal clinical trials of novel ophthalmic drugs and medical devices: retrospective observational study, 2002-2012Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization.A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host DiseaseA multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model.Biologic keratoprosthesis materialsContact lenses for drug delivery.Titanium back plate for a PMMA keratoprosthesis: clinical outcomes.The TFOS International Workshop on Contact Lens Discomfort: report of the management and therapy subcommittee.The TFOS International Workshop on Contact Lens Discomfort: executive summary.Collagen cross-linking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients.Protective effect of soft contact lenses after Boston keratoprosthesis.Topical drug formulations for prolonged corneal anesthesia.Reliable intraocular pressure measurement using automated radio-wave telemetry.In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.Cost-effectiveness of the Boston keratoprosthesis.Objective surgical assessments for residents and experienced surgeons in the Yelp Era.Revolutionary Future Uses of Contact Lenses.Results from the multicenter Boston Type 1 Keratoprosthesis Study.Visual Acuity Outcomes of the Boston Keratoprosthesis Type 1: Multicenter Study Results.Objective Assessment of Skills in Intraocular Surgery (OASIS)Retinal implants and Medicare reimbursement policies for breakthrough treatments in ophthalmology
P50
Q33292305-A23A18C8-9474-4A69-A45C-5D73EBC3D984Q33305301-2961C5E1-3CAC-4A57-9813-8F30C5A19B9BQ33997985-5B3B2C50-4C33-4CCF-91EB-2A6C9A91F0F9Q34020994-0CA3C716-2B35-4558-91B6-ABE18A599F20Q34402420-F469150F-AAF0-49C6-9666-1B20D0860D43Q35094304-B01E9B17-4957-49AB-A6F8-8B19455BB6C8Q35583088-BAF5A7FF-7298-4ED1-9845-5AF53DFC5CB5Q35691857-04BA1B7B-E46E-46BD-939B-4A4D4B636FF5Q36571709-4FFBC2CB-4541-401C-A7A4-C0921939677EQ37038747-CD16078E-3CF5-4980-BB06-BB6434ED752AQ37221040-A1981921-50DF-49FD-90FD-E51F01421149Q37362997-66A330CB-9F0B-4E86-9DEE-06034FA03695Q37479362-C5587125-EB38-44C3-9D0E-CE0E7222386AQ37868998-B438A8D2-253A-4291-8741-327986FEB9AEQ38140823-EB4F7725-BB83-42B2-AD25-556936D44E4FQ38140828-C73CDD7B-BE73-4057-9CA7-C808C6D80941Q38260715-7865D9B4-140C-427F-8933-A6E69232DE1AQ38567172-ADE5D226-4D30-4A45-8247-FFA974BB26F2Q39161226-510D89D6-1EDE-4CE8-81B4-4909EBE0A57AQ41871242-D9A7C050-FB85-4B19-A358-391BCFA86243Q42773028-E5FDC917-927E-48B0-B4FB-81C3700D4D2CQ45047028-56FDD816-66EF-46A6-8583-4DFCD71E684EQ46140894-636EE4DB-68AD-45DF-B7E0-2E689AF36871Q48168754-6AB2239E-4695-4D5C-82AD-6676FF7E8062Q51154969-4523C85B-DD94-4E4C-BBAE-7F5EC26BB379Q51652951-2D218B92-4E79-42FA-9600-02B254567408Q81794618-05E36672-703D-4AE8-898F-BD57D29DA043Q86714018-20BC9BFF-3062-4BAD-804A-85F5C8F6A592
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joseph B Ciolino
@ast
Joseph B Ciolino
@en
Joseph B Ciolino
@es
Joseph B Ciolino
@nl
type
label
Joseph B Ciolino
@ast
Joseph B Ciolino
@en
Joseph B Ciolino
@es
Joseph B Ciolino
@nl
prefLabel
Joseph B Ciolino
@ast
Joseph B Ciolino
@en
Joseph B Ciolino
@es
Joseph B Ciolino
@nl
P106
P1153
14068515900
P21
P31
P496
0000-0002-6223-3091